Zeta Global Holdings Corp (ZETA) concluded trading on Wednesday at a closing price of $18.01, with 4.11 million shares of worth about $74.01 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.87% during that period and on January 29, 2025 the price saw a loss of about -0.28%. Currently the company’s common shares owned by public are about 205.64M shares, out of which, 187.45M shares are available for trading.
Stock saw a price change of -4.61% in past 5 days and over the past one month there was a price change of -5.06%. Year-to-date (YTD), ZETA shares are showing a performance of 0.11% which increased to 81.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $9.35 but also hit the highest price of $38.20 during that period. The average intraday trading volume for Zeta Global Holdings Corp shares is 8.70 million. The stock is currently trading -1.53% below its 20-day simple moving average (SMA20), while that difference is down -10.16% for SMA50 and it goes to -15.69% lower than SMA200.
Zeta Global Holdings Corp (NYSE: ZETA) currently have 205.64M outstanding shares and institutions hold larger chunk of about 64.61% of that.
The stock has a current market capitalization of $4.28B and its 3Y-monthly beta is at 1.16. It has posted earnings per share of -$0.70 in the same period. It has Quick Ratio of 3.32 while making debt-to-equity ratio of 0.41. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZETA, volatility over the week remained 4.39% while standing at 5.40% over the month.
Stock’s fiscal year EPS is expected to rise by 148.91% while it is estimated to increase by 31.51% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on December 11, 2024 offering a Neutral rating for the stock and assigned a target price of $30 to it. On October 22, 2024, KeyBanc Capital Markets Initiated their recommendations, while on October 18, 2024, Barclays Downgrade their ratings for the stock with a price target of $28. Stock get an Equal-weight rating from Morgan Stanley on August 01, 2024.
